Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Sex Disparities in Outcomes Following Major Liver Surgery

View through CrossRef
Aim: To explore potential sex differences in outcomes and regenerative parameters post major hepatectomies. Background: Although controversial, sex differences in liver regeneration have been reported for animals. Whether sex disparity exists in human liver regeneration is unknown. Methods: Data from consecutive hepatectomy patients (55 females, 67 males) and from the international ALPPS (Associating-Liver-Partition-and-Portal-vein-ligation-for-Staged-hepatectomy, a two stage hepatectomy) registry (449 females, 729 males) were analyzed. Endpoints were severe morbidity (≥3b Clavien-Dindo grades), Model for End-stage Liver Disease (MELD) scores, and ALPPS interstage intervals. For validation and mechanistic insight, female-male ALPSS mouse models were established. t, χ2, or Mann-Whitney tests were used for comparisons. Univariate/multivariate analyses were performed with sensitivity inclusion. Results: Following major hepatectomy (Hx), males had more severe complications (P=0.03) and higher liver dysfunction (MELD) P=0.0001) than females. Multivariate analysis established male sex as a predictor of complications after ALPPS stage 1 (odds ratio=1.78; 95% confidence interval: 1.126–2.89; P=0.01), and of enhanced liver dysfunction after stage 2 (odds ratio=1.93; 95% confidence interval: 1.01–3.69; P=0.045). Female patients displayed shorter interstage intervals (<2 weeks, 64% females versus 56% males, P=0.01), however, not in postmenopausal subgroups. In mice, females regenerated faster than males after ALPPS stage 1, an effect that was lost upon estrogen antagonism. Conclusions: Poorer outcomes after major surgery in males and shorter ALPPS interstage intervals in females not necessarily suggest a superior regenerative capacity of female liver. The loss of interstage advantages in postmenopausal women and the mouse experiments point to estrogen as the driver behind these sex disparities. Estrogen’s benefits call for an assessment in postmenopausal women, and perhaps men, undergoing major liver surgery.
Title: Sex Disparities in Outcomes Following Major Liver Surgery
Description:
Aim: To explore potential sex differences in outcomes and regenerative parameters post major hepatectomies.
Background: Although controversial, sex differences in liver regeneration have been reported for animals.
Whether sex disparity exists in human liver regeneration is unknown.
Methods: Data from consecutive hepatectomy patients (55 females, 67 males) and from the international ALPPS (Associating-Liver-Partition-and-Portal-vein-ligation-for-Staged-hepatectomy, a two stage hepatectomy) registry (449 females, 729 males) were analyzed.
Endpoints were severe morbidity (≥3b Clavien-Dindo grades), Model for End-stage Liver Disease (MELD) scores, and ALPPS interstage intervals.
For validation and mechanistic insight, female-male ALPSS mouse models were established.
t, χ2, or Mann-Whitney tests were used for comparisons.
Univariate/multivariate analyses were performed with sensitivity inclusion.
Results: Following major hepatectomy (Hx), males had more severe complications (P=0.
03) and higher liver dysfunction (MELD) P=0.
0001) than females.
Multivariate analysis established male sex as a predictor of complications after ALPPS stage 1 (odds ratio=1.
78; 95% confidence interval: 1.
126–2.
89; P=0.
01), and of enhanced liver dysfunction after stage 2 (odds ratio=1.
93; 95% confidence interval: 1.
01–3.
69; P=0.
045).
Female patients displayed shorter interstage intervals (<2 weeks, 64% females versus 56% males, P=0.
01), however, not in postmenopausal subgroups.
In mice, females regenerated faster than males after ALPPS stage 1, an effect that was lost upon estrogen antagonism.
Conclusions: Poorer outcomes after major surgery in males and shorter ALPPS interstage intervals in females not necessarily suggest a superior regenerative capacity of female liver.
The loss of interstage advantages in postmenopausal women and the mouse experiments point to estrogen as the driver behind these sex disparities.
Estrogen’s benefits call for an assessment in postmenopausal women, and perhaps men, undergoing major liver surgery.

Related Results

[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED]Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Supplement Main Benefits - Helps Protect The ...
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED]Depiction • Where to Get Bottle Online –Click Here • Item Name -Bridport Health Liver • Aftereffects - No Major Side Effects • Classification - Health • Accessibility -O...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Requirement of vasculogenesis and blood circulation in late stages of liver growth in zebrafish
Requirement of vasculogenesis and blood circulation in late stages of liver growth in zebrafish
Abstract Background Early events in vertebrate liver development have been the major focus in previous studies, however, late events of liver organo...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
EVALUATION AND COMPARISON OF LIVER MARKERS IN ACUTE LIVER FAILURE VS CHRONIC LIVER FAILURE IN DISTRICT FAISALABAD: A CROSS-SECTIONAL STUDY
EVALUATION AND COMPARISON OF LIVER MARKERS IN ACUTE LIVER FAILURE VS CHRONIC LIVER FAILURE IN DISTRICT FAISALABAD: A CROSS-SECTIONAL STUDY
Background: Liver failure is a life-threatening clinical condition resulting from the inability of the liver to maintain its metabolic, synthetic, and detoxification functions. Acu...

Back to Top